1. Home
  2. IMMX vs RMIX Comparison

IMMX vs RMIX Comparison

Compare IMMX & RMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

N/A

Current Price

$7.92

Market Cap

784.8M

Sector

Health Care

ML Signal

N/A

Logo Suncrete Inc. Class A Common Stock

RMIX

Suncrete Inc. Class A Common Stock

N/A

Current Price

$5.24

Market Cap

772.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMX
RMIX
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
784.8M
772.3M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
IMMX
RMIX
Price
$7.92
$5.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
6
Target Price
★ $24.05
$20.83
AVG Volume (30 Days)
★ 1.2M
606.0K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$127.24
Revenue Next Year
N/A
$38.28
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.78
$8.02
52 Week High
$15.10
$25.50

Technical Indicators

Market Signals
Indicator
IMMX
RMIX
Relative Strength Index (RSI) 42.67 20.22
Support Level $7.82 N/A
Resistance Level $9.04 $12.59
Average True Range (ATR) 0.62 1.17
MACD 0.16 -0.25
Stochastic Oscillator 41.81 0.28

Price Performance

Historical Comparison
IMMX
RMIX

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About RMIX Suncrete Inc. Class A Common Stock

Suncrete Inc is a ready-mix concrete logistics and distribution platform operating across Oklahoma and Arkansas. Ready-mix concrete is a crucial building material that is used in the vast majority of infrastructure, commercial and residential construction projects. The company's ready-mix concrete business engages principally in the precise formulation, efficient production and on-time delivery of ready-mix concrete to the customers' job sites. It serves substantially all end markets of the construction industry in the select geographic markets. The company earns revenue prominently from the production and delivery of ready-mix concrete, with the majority revenue generated from orders under master purchase agreements or through direct sales to third-party contractors and suppliers.

Share on Social Networks: